From a race to a crawl: How delays derailed Covid-19 vaccination in Africa
In October 2021, the World Health Organization (WHO) announced a target of fully vaccinating 70% of each country’s population against…
All articles by Andrew Hillman
Andrew Hillman
@ajhillman_ddj
Andrew Hillman is a data journalist at GlobalData Media, specialising in healthcare and pharmaceutical coverage. He is a graduate of Birmingham City University's data journalism program and previously worked as an analyst and modeller in the emergency healthcare sector.
-
-
Tracking the rise of CAR-Ts in China: the dawn of an immunotherapy superpower?
Need to Know: To understand the evolution of the global CAR-T space, a Pharmaceutical Technology analysis paired drug and clinical…
-
Molnupiravir supplies dominate in times of Paxlovid scarcity
Despite the early and sustained enthusiasm for Pfizer’s oral antiviral Paxlovid, lagging supply has meant that most places in the…
-
Covid-19 antiviral access: uneven supply patterns hinder US rollout
The rapid development and authorization of Covid-19 therapeutics was meant to stem the impact of the tide of cases. But…
-
Filings buzz in pharma: 64% increase in internet of things mentions in Q2 of 2021
Mentions of the internet of things within the filings of companies in the pharmaceutical industry rose 64% between the first…
-
Anaesthesia drugs worst-hit by US drug shortages
Anaesthetics are the medicines most impacted by drug shortages in the US, an analysis of Food and Drug Administration (FDA)…
-
Filings buzz in pharmaceuticals: 34% decrease in industrial automation mentions in Q2 of 2021
Mentions of industrial automation within the filings of companies in the pharmaceutical industry fell 34% between the first and second…
-
Middle-income countries’ healthcare sectors to keep rising through to 2024
The healthcare sectors in middle-income countries is expected to outgrow those in high-income countries up until 2024. GlobalData figures show…
-
Filings buzz in pharmaceuticals: 25% increase in robotics mentions since Q2 2020
Mentions of robotics within the filings of companies in the pharmaceutical industry were 25% higher in the second quarter of…
-
Filings buzz in pharmaceuticals: 24% increase in artificial intelligence mentions in Q2 2021
Mentions of artificial intelligence within the filings of companies in the pharmaceutical industry rose 24% between the first and second…